Technology | May 15, 2012

Biotronik Introduces New External Pacemaker

Reocor offers intuitive operation and longevity


May 15, 2012 — Biotronik Inc., began its U.S. launch of its new Reocor external pacemaker. The device is available in two models, for dual- and single-chamber pacing therapy, and offers individualized patient therapy, easy handling and flexibility in every detail.

“Reocor has an intuitive design to simplify its utility. Clearly marked dials display selectable parameter values. The dials are simple and customers have told us that they’re perfect for visualizing programmed settings with just a quick glance,” commented Rex Richmond, vice president of marketing, Biotronik. “As a result, the device is easy to use without extensive training.”

The new device also features an extended longevity that increases reliability and reduces costs over time. Extended battery service times of up to 600 hours for permanent pacing therapy (with the Reocor S model), supplemented with a backup power supply during battery replacement, ensures easy handling and longer continuous usage in daily practice.

Reocor, which effectively delivers individual solutions for a broad range of patients, accommodates high pacing outputs and high pacing rates— a capability that is especially important when caring for pediatric patients.

For more information: www.biotronik.com


Related Content

News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
News | EP Lab

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
News | EP Lab

September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...

Home September 22, 2023
Home
News | EP Lab

August 17, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home August 17, 2023
Home
News | EP Lab

March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home March 28, 2023
Home
News | EP Lab

Nov. 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance ...

Home November 05, 2022
Home
News | EP Lab

October 14, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of ...

Home October 14, 2022
Home
Feature | EP Lab | By Vijay Kundekar

Arrhythmias can be described as irregular heart rhythms that are brought on by numerous factors, including heart damage ...

Home August 23, 2022
Home
News | EP Lab

May 24, 2022 — Attune Medical, a pioneering medical device company with a technology platform based on temperature ...

Home May 24, 2022
Home
News | EP Lab

May 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home May 04, 2022
Home
Subscribe Now